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Abstract
Background Identifying individuals with low grip strength is an initial step in many operational definitions of
sarcopenia. As evidence indicates that contemporaneous Russian populations may have lower mean levels of grip
strength than other populations in northern Europe, we aimed to: compare grip strength in Russian and Norwegian
populations by age and sex; investigate whether height, body mass index, education, smoking status, alcohol use
and health status explain observed differences and; examine implications for case-finding low muscle strength.
Methods We used harmonized cross-sectional data on grip strength and covariates for participants aged 40–69 years
from the Russian Know Your Heart study (KYH) (n = 3833) and the seventh survey of the Norwegian Tromsø Study
(n = 5598). Maximum grip strength (kg) was assessed using the same protocol and device in both studies. Grip
strength by age, sex and study was modelled using linear regression and between-study differences were predicted
from these models. Sex-specific age-standardized differences in grip strength and in prevalence of low muscle strength
were estimated using the European population standard of 2013.
Results Normal ranges of maximum grip strength in both studies combined were 33.8 to 67.0 kg in men and 18.7 to
40.1 kg in women. Mean grip strength was higher among Tromsø than KYH study participants and this difference did
not vary markedly by age or sex. Adjustment for covariates, most notably height, attenuated between-study differences
but these differences were still evident at younger ages. For example, estimated between-study differences in mean grip
strength in fully adjusted models were 2.2 kg [95% confidence interval (CI) 1.4, 3.1] at 40 years and 1.0 kg (95% CI
0.5, 1.5) at 65 years in men (age × study interaction P= 0.09) and 1.1 kg (95% CI 0.4, 1.9) at age 40 years and0.2 kg
(95% CI 0.7, 0.3) at 65 years in women (age × study interaction P < 0.01).
Conclusions We found between-study differences in mean grip strength that are likely to translate into greater future
risk of sarcopenia and poorer prospects of healthy ageing for Russian than Norwegian study participants. For example,
the average Russian participant had a similar level of grip strength to a Norwegian participant 7 years older. Our find-
ings suggest these differences may have their origins in childhood highlighting the need to consider interventions in
early life to prevent sarcopenia.
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Introduction
Age-related declines in muscle function and mass pose a ma-
jor threat to healthy ageing and the maintenance of indepen-
dence in later life. When levels of muscle function and mass
fall below clinical thresholds this is referred to as sarcopenia.
The assignment of an ICD-10 code1 to this ‘progressive and
generalized skeletal muscle disorder’,2 which has major per-
sonal and societal impacts,3,4 reflects growing recognition of
its clinical importance.
Challenges remain in achieving the aim of a universally
agreed, unified operational definition of sarcopenia.5 In
2018, the European Working Group on Sarcopenia in Older
People (EWGSOP2), whose work has gained considerable
attention, published an updated consensus on the definition
and diagnosis of sarcopenia.6 According to EWGSOP2’s recom-
mendations, one of the initial steps in case-finding sarcopenia
is to identify individuals with low muscle strength. Where low
muscle strength is identified, sarcopenia is considered proba-
ble, and in clinical practice, this is considered sufficient to trig-
ger assessment of causes and initiate intervention. It is also
only if low muscle strength is found that assessments of mus-
cle quantity or quality are recommended. As the EWGSOP2
recommend applying universal cut-points to grip strength
to identify low muscle strength, any between-country
differences in grip strength would therefore be expected to
impact on the prevalence of sarcopenia detected. Understand-
ing the scale of between-country differences in grip strength
by age and sex and investigating the factors that may explain
these differences is therefore important.
In a systematic review that synthesized published norma-
tive grip strength data from seven different UN regions,
marked variations in grip strength across the life course were
documented.7 These meta-analyses showed that grip
strength was generally higher in high-income than in
low-income and middle-income countries. Similar observa-
tions were made in the PURE study that assessed grip
strength in adults aged 35 to 70 years residing in 21 countries
in different world regions. In this study, the highest mean grip
strength values were recorded in Europe and North America
and the lowest in South and South East Asia and Africa.8 Dif-
ferences in grip strength between countries in different
world regions7–10 are to be expected given major differences
in lifetime exposures and body size and composition. How-
ever, it is noteworthy that a number of studies have also re-
ported variation in grip strength between different
populations within Europe.11–15 In one of these studies, par-
ticipants of similar ages from Moscow, England, and
Denmark were compared. The Russian participants were
weaker than English and Danish participants at all ages up
to 80 years. Despite these differences, associations of grip
strength with mortality rate ratios were similar in all three
settings.14 The explanation of differences in grip strength be-
tween contemporaneous Russian and other northern Euro-
pean populations, which may in part be the result of the
very different mortality and health profiles and past
unfavourable health experiences of Russians compared with
most other Europeans,16,17 requires further investigation.
This is especially as the Russian sample analysed was from
Moscow, which has a higher average level of educational at-
tainment and income than Russians residing in other regions
of the country.14
Using harmonized data from the Russian Know Your Heart
(KYH) study and the seventh survey of the Norwegian Tromsø
Study (Tromsø 7), we aimed to: compare grip strength by age
and sex in Russian and Norwegian populations aged 40–
69 years; investigate specific factors that may explain ob-
served differences and; examine the implications of any ob-
served differences in mean levels of grip strength for the
case-finding of low muscle strength.
Methods
Study populations
The KYH study is a cross-sectional survey of men and women
residing in two Russian cities; Novosibirsk (the third largest
city in Russia with a population of ~1.5 million) and
Arkhangelsk (with a population of ~350 000).18 The study
population comprises men and women aged 35–69 years
recruited from the general population using random
sampling of addresses from regional health insurance
databases. Participants were assessed during fieldwork
conducted between November 2015 and January 2018. KYH
included two study components; a baseline interview
conducted at the study participant’s home, and a health
check at a primary care clinic, which included grip strength
testing. After exclusion of invalid addresses and those
addresses where no residents were of the anticipated age
and sex, the percentage of participants invited who
attended the health check was 66% in Arkhangelsk and 34%
in Novosibirsk.18 A total of 5089 men and women
participated in the baseline interview of whom 4504
attended the health check. Of these attendees, there were
3939 participants aged 40–69 years, and 3833 with valid
grip strength measurements (106 did not participate in grip
strength testing due to health problems or other reasons).
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The Tromsø Study is a longitudinal study of men and
women residing in the municipality of Tromsø, Norway
(with a population of ~75 000). In the seventh survey
(Tromsø 7), conducted between March 2015 and October
2016,19,20 all Tromsø residents aged 40 years and older
were invited to participate. In the first phase of Tromsø 7, a
total of 21,083 (65% response) men and women
participated in an assessment including questionnaires,
interviews, biological sampling, and clinical examination of
whom 17 646 were aged 40–69 years. A random sample of
participants (n = 6,608 aged 40–69 years) were then invited
to participate in a second phase of additional clinical
assessments including grip strength. Of those participants
aged 40–69 years included in the second phase, 5598 had
valid grip strength measurements (seven did not participate
in grip strength testing due to health problems or other
reasons).
The KYH study received ethical approval from the ethics
committees of the London School of Hygiene & Tropical
Medicine (approval number 8808), Novosibirsk State
Medical University (approval number 75), the Institute of
Preventative Medicine, Novosibirsk, and the Northern State
Medical University, Arkhangelsk (approval number 01/01-
15). Tromsø 7 was approved by the Regional Committee of
Medical and Health Research Ethics (REC North approval
number 2014/940) and the Norwegian Data Protection
Authority. All participants in the KYH and Tromsø 7 studies
provided written informed consent.
Assessment of grip strength
Key aspects of the KYH study protocol were designed to be di-
rectly comparable with Tromsø 7.18 In both studies, grip
strength was assessed by trained health professionals using
Jamar+ Digital Dynamometers following the Southampton
protocol.21 This involved participants being asked to sit in a
chair holding the dynamometer while resting their arm on
the chair’s armrest with their elbow bent at a 90° angle and
their hand positioned thumbs up. The same hand setting on
the dynamometer was used for all participants. Participants
received verbal encouragement from the tester to squeeze
as hard as they could during each test. Three measurements
were taken for each hand, alternating between right and left
hands, and the maximum value achieved from all six mea-
surements was used in analyses.
EWGSOP2 cut-points were applied (grip strength: men
<27 kg and women <16 kg) to identify those with low mus-
cle strength.6 These cut-points are based on a T score of 2.5
when using normative data from 12 British studies. As it has
been suggested that a cut-point of 2.5 may be too conser-
vative, we also examined a cut-point of 2.0 (men <32 kg
and women <19 kg).22
Covariates
In order to investigate potential explanations of any
between-study differences in grip strength observed, we se-
lected a priori to study the following covariates: height; body
mass index (BMI); education; smoking; alcohol use and;
health status. These covariates had all been ascertained in
comparable ways in the two studies. Height (m) and weight
(kg) were measured, and BMI was calculated (kg/m2). Educa-
tion was self-reported and grouped into three categories:
incomplete secondary, secondary, higher. Smoking status
was categorized as never, ex or current smoker. Alcohol con-
sumption was assessed using the Alcohol Use Disorders
Identification Test (AUDIT), a 10-item questionnaire with
sum scores ranging from 0 to 40, where higher values indi-
cate more harmful drinking.23 Three dichotomous health
status variables were derived to indicate the presence or
absence of self-reported: (i) arthritis or osteoarthritis, (ii)
myocardial infarction/heart attack or stroke, and (iii)
diabetes.
Statistical analyses
Estimation of grip strength [with 95% confidence intervals
(CI)], and between-study differences in grip strength were
modelled using linear regression taking account of age and
sex. To allow for variation in between-study differences in
grip strength by sex and age, the interaction terms sex by
age by study, sex by age, sex by study, and study by age were
included and from these models mean grip strengths by age,
sex and study were predicted. We also reran models in men
and women separately, which included age, study, and age
by study interaction terms. In addition, for comparative pur-
poses, mean grip strength was age-standardized, using the di-
rect method, in 5 year age bands (40–44, 45–49, …, 65–69)
using the European population standard of 2013.24 These
analyses included all 9431 participants (3833 in KYH and
5598 in Tromsø 7) with valid grip strength measures.
To investigate factors that may explain observed
between-study differences in grip strength, each covariate
was added to the main linear regression model (i.e. a model
including age, sex, and study and their interactions) by itself
in turn before models were run in which height, then BMI,
then all other covariates (i.e. education, smoking, alcohol
use, and health status) were included. These models were
all run on the sample with complete data on covariates
[n = 8965 (3812 in KYH and 5153 in Tromsø 7)]—data were
missing on BMI (n = 10 KYH, n = 14 Tromsø 7); height (n = 2
KYH, n = 12 Tromsø 7); alcohol use (n = 10 KYH, n = 377
Tromsø 7); smoking (n = 1 KYH, n = 38 Tromsø 7); education
(n = 0 KYH, n = 60 Tromsø 7).
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Analyses of low grip strength
Sex-specific age-standardized prevalence of low muscle
strength was estimated using the European population stan-
dard of 2013 for the full age range (40–69 years) as well as
for the age range 60–69 years. Between-study differences in
age-standardized prevalence of low muscle strength in men
and women were estimated and tested in linear regression
using the survey prefix (svy) command in Stata.
Sensitivity analyses
As a 1 kg difference in grip strength represents a smaller pro-
portion of a standard deviation in men than women, the main
analyses were repeated using sex-standardized grip strength
values. These values were calculated as (x-meani)/SDj where
x is the observed measure of grip strength and meanj and
SDj are the sample mean and SD of grip strength for sex j.
To test the impact of restricting adjusted analyses to the sam-
ple with complete data on covariates, we reran basic models
on a larger sample (n = 9407) who had only height and BMI
data missing.
Results
Characteristics of the two study populations are shown in
Table 1. Tromsø 7 participants were on average older and
taller and more likely to report higher levels of education
and lower prevalence of specified health conditions than
KYH participants. Mean BMI in the men from the two studies
were similar, but differences were observed among women
(28.9 kg/m2 in KYH vs. 26.7 kg/m2 in Tromsø 7) due to greater
mean weight and also shorter mean height of women in KYH
than Tromsø 7. Current smoking was more prevalent among
KYH than Tromsø 7 participants and this difference was much
more pronounced among men. Alcohol use scores were sim-
ilar among men in the two studies. Although alcohol use
scores in women from both studies were lower than those
among men, women from Tromsø 7 had higher scores than
women from KYH.
Normal ranges of maximum grip strength for both studies
combined were 33.8 to 67.0 kg in men and 18.7 to 40.1 kg in
women. These normal ranges varied by age group and study
(supporting information Table S1).
In basic descriptive models, in all age groups and in both
sexes, mean grip strength was higher among Tromsø 7 than
KYH participants (refer to Figure 1 and Table S2). There was
no evidence in these models that the differences in mean grip
strength between studies varied by age in either sex (P values
for age × study interactions in men = 0.89 and in
women = 0.19) or that the study differences varied by sex
(P value for study × sex × age interaction = 0.59).
Based on predicted estimates from a regression model in-
cluding grip strength, age, sex, and study; and interaction
terms between these three covariates, among men, mean
Table 1 Characteristics of the Know Your Heart (KYH) and Tromsø 7 study participants (N = 9431)a included in the main analyses
Descriptive statisticsb
Men Women
KYH Tromsø 7 KYH Tromsø 7
Age (years) 55.7 (8.3) 1622 58.6 (8.3) 2552 55.3 (8.4) 2211 58.3 (8.3) 3046
Height (cm) 174.9 (6.7) 1622 177.8 (6.7) 2548 161.1 (6.1) 2209 164.4 (6.3) 3038
Body mass index (kg/m2) 27.7 (4.8) 1619 27.9 (4.0) 2548 28.9 (6.2) 2204 26.7 (4.7) 3036
Education
Incomplete secondary 141 (9) 581 (23) 124 (6) 713 (24)
Secondary 842 (52) 744 (29) 1209 (55) 842 (28)
Higher 639 (39) 1203 (48) 878 (40) 1455 (48)
Alcohol use scorec 4 (2, 7) 1615 4 (3, 6) 2397 1 (1, 3) 2208 3 (2, 4) 2824
Smoking status
Never 449 (28) 1001 (39) 1526 (69) 1129 (37)
Ex 588 (36) 1191 (47) 319 (14) 1453 (48)
Current 585 (36) 345 (14) 365 (17) 441 (15)
Myocardial infarction/Heart attack or stroke
No 1431 (88) 2352 (92) 2065 (93) 2956 (97)
Yes 191 (12) 200 (8) 146 (7) 90 (3)
Arthritis or osteoarthritis
No 1244 (77) 2183 (86) 1382 (63) 2197 (72)
Yes 378 (23) 369 (15) 829 (37) 849 (28)
Diabetes
No 1497 (92) 2390 (94) 2000 (90) 2902 (95)
Yes 125 (8) 162 (6) 211 (10) 144 (5)
aMaximum N = 9431. This includes all study participants aged 40–69 years with valid data on grip strength but Ns vary due to missing
data on covariates.
bMean (SD) N for age, height and body mass index; median (q25, q75) N for alcohol use score; N (%) for all other variables.
cAlcohol Use Disorders Identification Test (AUDIT) score with range 0–40, where higher values indicate more harmful drinking.
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grip strength was 3.0 kg (95% CI 2.1, 3.9) lower in KYH com-
pared with Tromsø 7 participants at age 40 years, and
3.1 kg (95% CI 2.5, 3.6) lower at age 65 years (Figure 2). Ad-
justment for height attenuated between-study differences,
especially at older ages—in the model adjusted for height, es-
timated between study differences in mean grip strength
were 2.6 kg (95% CI 1.7, 3.4) at 40 years and 1.3 kg (95% CI
0.8, 1.9) at 65 years. The addition of BMI had minimal impact,
and in the fully adjusted model with inclusion of all covari-
ates, differences in mean grip strength, though attenuated,
were still observed at all ages—estimated between study dif-
ferences in mean grip strength in this model were 2.2 kg (95%
CI 1.4, 3.1) at 40 years and 1.0 kg (95% CI 0.5, 1.5) at 65 years
(age × study interaction P = 0.09).
Among women, in the initial model, mean grip strength
was 1.9 kg (95% CI 1.1, 2.7) lower in KYH compared with
Tromsø 7 participants at age 40 years, and 1.5 kg (95% CI
1.0, 2.0) lower at age 65 years (Figure 2). Height substantially
attenuated these between study differences, especially at
older ages—in the model adjusted for height, estimated be-
tween study differences in mean grip strength were 1.3 kg
(95% CI 0.5, 2.0) at 40 years and 0.3 kg (95% CI -0.8, 0.2)
at 65 years. Thus, after adjustment for height, there was no
evidence of a difference in mean grip strength between older
KYH and Tromsø 7 women participants, whereas differences
were still observed at younger ages. The addition of other co-
variates had only minimal impact and in the fully adjusted
model estimated between study differences were 1.1 kg
(95% CI 0.4, 1.9) at age 40 years and 0.2 kg (95% CI 0.7,
0.3) at 65 years (age × study interaction P < 0.01).
Although differences in mean grip strength between stud-
ies were observed across the full age-range, there was limited
evidence of differences in the age-standardized prevalence of
low muscle strength when the EWGSOP2 cut-off points were
applied to the full sample (Table 2). However, when esti-
mated for older ages (i.e. 60–69 years) only, age-standardized
prevalence estimates of low muscle strength were higher in
KYH compared with Tromsø 7 women (Table 2, Figure S1).
Using a less conservative cut-off point, the age-standardized
prevalence of low grip strength in men aged 40–69 years
was 1.0% in Tromsø 7 and 1.1% in KYH (P = 0.76 for test of
difference) and in women was 1.9% in Tromsø 7 and 2.8%
in KYH (P = 0.03 for test of difference). These differences in
prevalence were more pronounced when estimates were re-
stricted to those aged 60–69 years [men: 1.8% in Tromsø 7 vs.
3.0% in KYH (P = 0.05 for test of difference) and women: 2.5%
in Tromsø 7 vs. 6.0% in KYH (P < 0.001 for test of
difference)].
Findings were very similar when grip strength was
sex-standardized (Figure S2) with these results confirming
that the scale of between-study differences were similar in
men and women and that the larger absolute
between-study differences in grip strength observed among
men than women (refer to Figures 1 and 2) were attributable
to the greater variance in grip strength among men. Findings
were also very similar, and conclusions remained the same
when analyses were rerun on a larger sample size (Figure S3).
Discussion
Among a large contemporary sample of community-dwelling
men and women aged 40 to 69 years, we found clear and
Figure 1 Mean grip strength (kg) (95% confidence intervals) by age and study in men and women. Estimated in sex-specific linear regression models
including age, study, and an age by study interaction (N = 9431). *Dots are unadjusted observed means (blue for Tromsø 7 and red for Know Your Heart
Study)
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consistent evidence of weaker mean grip strength among
Russian than Norwegian study participants. This translated
into modest differences in the prevalence of low muscle
strength in participants aged 60–69 years. Despite the pres-
ence of marked sex and age differences in grip strength in
both studies as expected,22,25 in basic models, there was no
Table 2 Prevalence (%) of low muscle strength by age, sex and study (using European Working Group on Sarcopenia in Older People (EWGSOP2) and
alternative cut-points
a
) (N = 9431)
Cut-points
EWGSOP2 recommendation
(<27 kg men, <16 kg women)
Less conservative alternative
(<32 kg men, <19 kg women)
Men Women Men Women
Age (years) KYH Tromsø 7 KYH Tromsø 7 KYH Tromsø 7 KYH Tromsø 7
40–44 0.0 0.0 0.0 0.7 0.5 0.0 1.5 0.7
45–49 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.9
50–54 0.0 0.8 0.8 1.2 0.7 1.6 2.7 2.7
55–59 0.7 0.0 0.0 0.7 1.1 0.3 3.8 2.1
60–64 0.6 0.8 1.2 0.4 2.7 1.5 5.6 1.3
65–69 1.9 0.5 2.5 0.7 3.3 2.1 6.4 3.7
Age-standardizedb
prevalence estimate




































aEWGSOP26 recommended cut-points for low muscle strength based on a T score of 2.5 when using normative grip strength data from
12 British studies22 the less conservative alternative applied is based on a T score of 2.0 using the same reference data.
bAge-standardized using the European population standard of 2013.
*Test of difference in age-standardized prevalence estimate between Tromsø 7 and Know Your Heart study participants, P< 0.05. P values
are calculated separately for men and women.
Figure 2 Absolute differences in mean grip strength (kg) (95% confidence intervals) between Know Your Heart and Tromsø 7 study participants by age
and sex estimated in linear regression models with and without adjustments for covariates (Tromsø 7 is the reference line at 0) (N = 8965). Footnotes:
In all models, age is modelled linearly including all its three-ways and two-ways interactions with study and sex. Fully adjusted model includes: eight,
body mass index, education, smoking status, alcohol use and health status (indicated by presence or absence of self-reported myocardial infarction/
heart attack or stroke; arthritis or osteoarthritis; diabetes). P values presented are from tests of interaction between age and study.
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clear evidence that between-study differences in grip
strength varied by age or sex. Adjustment for covariates, spe-
cifically height, attenuated the observed between-study dif-
ferences at all ages and in both sexes but more so among
older than younger participants and especially among
women.
Our finding of weaker mean grip strength among Russian
than Norwegian study participants is consistent with previ-
ous findings but provides a number of novel insights. In a
comparison of the grip strength of men and women aged
55 to 89 years from three studies, participants from
Moscow were found to be weaker on average than those
from England and Denmark.14 The authors of this paper
noted that differences in grip strength between Russian
and other north European populations may be even larger
than they had estimated because of the higher average
levels of educational attainment and income among their
Muscovite sample than the general Russian population. This
is a potential limitation that we address by studying popula-
tions from two other regions of Russia selected to represent
a range of different socio-demographic levels.18 By including
younger adults, our study is also able to provide other valu-
able new insights. Most importantly, it demonstrates that
differences in grip strength between Russian and other
north European populations are evident by age 40 years
prior to the onset of declines in muscle function that are
generally seen at older ages. This suggests a potentially im-
portant role for factors in earlier life that influence the de-
velopment of peak muscle strength in explaining observed
between-study differences.
Consistent with the suggestion that early life factors are
important is our finding that height, which has its origins in
childhood,26 was the potential explanatory factor investi-
gated that had the most marked impact on observed
between-study differences in grip strength. This is particu-
larly notable given we also adjusted for markers of health sta-
tus and health behaviours in adulthood. Because of the
well-documented adverse health profiles of Russian adults
compared with other European populations,16,17 we had ex-
pected that these factors, which precipitate age-related de-
clines in function, may be most important in explaining
between-study differences in grip strength.
That adjustment for height attenuated differences in grip
strength to a greater extent among older than younger
participants is explained by the smaller between-study dif-
ferences in mean height among younger than older partici-
pants. This is consistent with published data on secular
trends in height showing that mean adult heights in Russia
and Norway have converged over the course of the twenti-
eth century.27 This is most likely because study participants
from more recent born cohorts, especially those from
Russia,28 have benefited more from improvements in early
life conditions (including better nutrition and reduced risk
of serious childhood infections) than those from older
cohorts.
Our study has a number of key strengths that give us con-
fidence that the between-study differences in grip strength
observed are real and very unlikely to be attributable to
methodological artefacts. These include the use of the same
model of dynamometer and identical grip strength measure-
ment protocols. This is important given there are significant
measurement differences in grip strength when different
types of dynamometer and measurement protocols are
employed.29,30 In addition, we have been able to comprehen-
sively investigate explanations of between-study differences
in grip strength due to the availability of data on a range of
covariates assessed using comparable methods. However,
we acknowledge that due to limitations in the variables avail-
able we may not have taken account of variation in all rele-
vant aspects of health status. In addition, there are other
factors we could not investigate that may explain differences
in grip strength still observable in fully adjusted models at
younger ages. Unfortunately, these other factors, including
physical activity, fat, and lean mass and indicators of child-
hood development and circumstances, had not been
assessed in one or both studies or had not been assessed
comparably and so these warrant investigation in future
studies.
Another strength of our study is the wide age range of par-
ticipants. This allowed us to formally assess whether
between-study differences were observed from midlife and
varied by age across 30 years of the adult life course. How-
ever, as these data are cross-sectional, we cannot make infer-
ences about rates of loss, and we recognize that observed
differences in grip strength by age could be attributable to
age, cohort, and/or period effects. As there was variation be-
tween studies in (i) levels of participation; (ii) the number of
participants who had to be excluded as they were unable to
complete the grip strength test for health reasons; (iii) the
number of participants with missing data on covariates, we
acknowledge that bias may have been introduced. However,
KYH study participants were largely representative of the
Russian urban population in terms of age and educational
status when compared with the Russian 2010 census.18 As a
greater number of KYH than Tromsø 7 participants were ex-
cluded from analyses as they could not complete the grip
strength tests for health or other reasons (106 vs. 7) and
these participants would be expected to have weaker
strength,31 our estimates of between-study differences are
likely to be conservative. In addition, there was no evidence
that exclusion of participants with missing data had a major
impact as when we reran analyses on a less restricted sample,
findings remained the same. Finally, we should note that the
KYH dynamometers were sent to the UK for calibration
post-assessment at which point one of the four dynamome-
ters used in Novosibirsk was found to be broken and
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systematically measuring 2.5 kg higher. We are unsure when
the device was broken as it was not reported by any of the
assessors and could have happened in transit back to the
UK. We could find no evidence that any of the assessors re-
corded systematically higher grip strength measures. In addi-
tion, when we compared mean grip strength values in
Tromsø 7 with KYH participants from Arkhangelsk only, our
estimates of between-study differences were very similar.
We are therefore confident that this had no or very little im-
pact on our findings and, as the error detected would have
resulted in higher measurements among some Russian partic-
ipants, if this had any impact, it would have led to more con-
servative estimates of between-study differences.
The differences in mean grip strength observed in our
analyses translated into modest between-study differences
in the prevalence of low muscle strength, as per EWGSOP2
and alternative criteria, at older ages only. That differences
in the prevalence of low muscle strength were not detected
at younger ages reflects the fact that before age 60,
age-related declines in grip strength would not yet have been
expected to reach sufficient magnitude for many people to
fall below proposed clinical thresholds. However, as the scale
of between-study differences in grip strength were very sim-
ilar across all ages in basic models and these differences were
not fully explained by adjustment for covariates in younger
adults the implication of this is that Russian participants will
be at greater risk of low muscle strength and hence
sarcopenia in coming years as they continue to age and even
if they experience similar rates of age-related decline to Nor-
wegian participants. To put the scale of the between-study
differences in perspective, we can use estimated differences
in grip strength by age (which were 0.05 SD per year in
men and 0.04 SD per year in women) and apply these to
the overall age-adjusted study differences in grip strength
of 0.35 SD (95% CI 0.29, 0.41) in men and 0.30 SD (95% CI
0.25, 0.35) in women. When we do this, the between-study
differences in grip strength we observe correspond to an
age difference of 7.0 years in men and 7.5 years in women.
In conclusion, we have shown that male and female study
participants from Russia have consistently lower mean levels
of grip strength than those from Norway between ages 40
and 69 years. As grip strength is commonly used to identify
sarcopenia and has been proposed as a general biomarker
of ageing,32,33 these between-study differences may translate
into greater future risk of sarcopenia and poorer prospects of
healthy ageing for Russian than Norwegian study partici-
pants. We also provide evidence to suggest that these differ-
ences may have their origins in early life supporting the need
for life course approaches to the prevention of sarcopenia
and promotion of healthy ageing. Strategies that promote
muscle development in early life are likely to be an essential
complement to those that minimize age-related declines in
later life.
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and women estimated using linear regression models
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(<27 kg for men, <16 kg for women) and less conservative
values (<32 kg for men, <19 kg for women)).
Figure S2. Absolute differences in mean sex-standardised grip
strength (z-scores) (95% confidence intervals) between Know
Your Heart and Tromsø 7 study participants by age and sex
estimated in linear regression models with and without ad-
justments for covariates (Tromsø 7 is the reference line at
0) (N = 8,965).
Note: Age is modelled linearly including all its 3-and 2-ways
interactions with study and sex. Fully adjusted model in-
cludes: height, BMI, education, smoking status, alcohol use
and health status (indicated by presence or absence of
self-reported myocardial infarction/heart attack or stroke; ar-
thritis or osteoarthritis; diabetes). P-values for interaction be-
tween age and study.
Figure S3. Absolute differences in mean grip strength (kg)
(95% confidence intervals) between Know Your Heart and
Tromsø 7 study participants by age and sex estimated in lin-
ear regression models with and without adjustment for
height and BMI (Tromsø 7 is the reference line at 0).
Sensitivity analysis to compare unadjusted and height and
BMI adjusted analyses run on main analytical sample with
complete data on all covariates (n = 8,965) and a larger sam-
ple (n = 9,407) with complete data on height and BMI.
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